Skip to content
Disclosery

Rhenman & Partners Asset Management AB

Follow

13F filer, CIK 1599882, Stockholm, Sweden

Rhenman & Partners Asset Management AB reported $1,069,994,013 across 94 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13. Its ten largest share positions make up 29.4% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001213900-26-015821

Period
2025-12-31
Reported value
$1.07B
Holdings
94
Top 10 weight
29.4%
New
13
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
REGNadded+25,300$19.5M
VERAadded+290,000$14.7M
AMGNnew+36,000$11.8M
NUVLadded+110,850$11.2M
DOCSadded+236,750$10.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EXASexited-348,000-$19M
CAHexited-94,000-$14.8M
CYTKreduced-210,875-$13.4M
ABTexited-98,500-$13.2M
LLYreduced-11,200-$12M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001213900-26-015821, largest first. % of portfolio is the value over $1,069,994,013, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 39,000 shares; 2024Q4: 43,457 shares; 2025Q1: 31,750 shares; 2025Q2: 27,700 shares; 2025Q3: 36,100 shares; 2025Q4: 61,400 shares 61,400$47.4M4.43%+25,300Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 47,500 shares; 2024Q4: 45,450 shares; 2025Q1: 41,750 shares; 2025Q2: 57,870 shares; 2025Q3: 53,420 shares; 2025Q4: 42,220 shares 42,220$45.4M4.24%-11,200Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 590,000 shares; 2024Q4: 444,000 shares; 2025Q1: 300,000 shares; 2025Q2: 296,000 shares; 2025Q3: 438,000 shares; 2025Q4: 431,207 shares 431,207$41.1M3.84%-6,793Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 368,000 shares; 2024Q4: 269,500 shares; 2025Q1: 255,000 shares; 2025Q2: 179,500 shares; 2025Q3: 205,000 shares; 2025Q4: 296,000 shares 296,000$28.4M2.66%+91,000Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 63,000 shares; 2024Q4: 64,000 shares; 2025Q1: 51,500 shares; 2025Q2: 44,350 shares; 2025Q3: 48,500 shares; 2025Q4: 48,000 shares 48,000$27.2M2.54%-500Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 228,000 shares; 2024Q4: 115,000 shares; 2025Q1: 236,000 shares; 2025Q2: 170,000 shares; 2025Q3: 237,000 shares; 2025Q4: 327,500 shares 327,500$26.8M2.51%+90,500Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 184,000 shares; 2024Q4: 267,500 shares; 2025Q1: 235,862 shares; 2025Q2: 295,362 shares; 2025Q3: 277,362 shares; 2025Q4: 335,500 shares 335,500$26.6M2.49%+58,138Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 177,000 shares; 2024Q4: 124,150 shares; 2025Q1: 88,650 shares; 2025Q2: 69,375 shares; 2025Q3: 130,375 shares; 2025Q4: 110,575 shares 110,575$25.3M2.36%-19,800Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 111,000 shares; 2024Q4: 36,531 shares; 2025Q1: 270,000 shares; 2025Q2: 235,000 shares; 2025Q3: 230,000 shares; 2025Q4: 210,000 shares 210,000$23.7M2.22%-20,000Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 83,302 shares; 2024Q4: 63,952 shares; 2025Q1: 41,952 shares; 2025Q2: 121,452 shares; 2025Q3: 134,452 shares; 2025Q4: 99,052 shares 99,052$22.7M2.12%-35,400Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 45,150 shares; 2024Q4: 53,750 shares; 2025Q1: 32,375 shares; 2025Q2: 49,375 shares; 2025Q3: 62,375 shares; 2025Q4: 63,375 shares 63,375$21.4M2%+1,000Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,000 shares; 2025Q4: 420,000 shares 420,000$21.3M1.99%+290,000Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,117 shares; 2024Q4: 34,117 shares; 2025Q1: 47,217 shares; 2025Q2: 27,717 shares; 2025Q3: 26,600 shares; 2025Q4: 25,600 shares 25,600$21M1.96%-1,000Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 122,600 shares; 2024Q4: 122,600 shares; 2025Q1: 109,600 shares; 2025Q2: 90,800 shares; 2025Q3: 172,800 shares; 2025Q4: 114,800 shares 114,800$21M1.96%-58,000Timeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,977,363 shares; 2024Q4: 1,761,192 shares; 2025Q1: 1,337,284 shares; 2025Q2: 1,287,284 shares; 2025Q3: 1,479,284 shares; 2025Q4: 1,009,450 shares 1,009,450$19.9M1.86%-469,834Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,513 shares; 2024Q4: 61,500 shares; 2025Q1: 185,500 shares; 2025Q2: 175,435 shares; 2025Q3: 131,885 shares; 2025Q4: 113,585 shares 113,585$19.8M1.85%-18,300Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,100 shares; 2024Q4: 15,640 shares; 2025Q1: 12,640 shares; 2025Q2: 11,140 shares; 2025Q3: 30,040 shares; 2025Q4: 33,640 shares 33,640$19.5M1.82%+3,600Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 445,000 shares; 2024Q4: 420,345 shares; 2025Q1: 448,000 shares; 2025Q2: 190,000 shares; 2025Q3: 390,000 shares; 2025Q4: 611,000 shares 611,000$19.2M1.8%+221,000Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,350 shares; 2024Q4: 17,000 shares; 2025Q1: 48,197 shares; 2025Q2: 51,197 shares; 2025Q3: 31,875 shares; 2025Q4: 45,675 shares 45,675$18.2M1.7%+13,800Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 72,700 shares; 2024Q4: 60,530 shares; 2025Q1: 77,430 shares; 2025Q2: 30,430 shares; 2025Q3: 62,530 shares; 2025Q4: 54,900 shares 54,900$18.1M1.69%-7,630Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 71,750 shares; 2024Q4: 100,317 shares; 2025Q1: 89,817 shares; 2025Q2: 149,217 shares; 2025Q3: 114,717 shares; 2025Q4: 125,491 shares 125,491$17.8M1.66%+10,774Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,000 shares; 2024Q4: 57,000 shares; 2025Q1: 61,000 shares; 2025Q2: 46,000 shares; 2025Q3: 58,000 shares; 2025Q4: 61,000 shares 61,000$17.3M1.62%+3,000Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 21,000 shares; 2025Q3: 136,000 shares; 2025Q4: 372,750 shares 372,750$16.5M1.54%+236,750Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares; 2025Q3: 155,000 shares; 2025Q4: 193,500 shares 193,500$16.5M1.54%+38,500Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 90,000 shares; 2024Q4: 72,500 shares; 2025Q1: 52,500 shares; 2025Q2: 52,500 shares; 2025Q3: 52,500 shares; 2025Q4: 163,350 shares 163,350$16.4M1.54%+110,850Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 67,100 shares; 2024Q4: 123,700 shares; 2025Q1: 49,500 shares; 2025Q2: 12,000 shares; 2025Q3: 55,000 shares; 2025Q4: 92,350 shares 92,350$16.3M1.52%+37,350Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 47,750 shares; 2024Q4: 50,000 shares; 2025Q1: 66,750 shares; 2025Q2: 61,455 shares; 2025Q3: 46,955 shares; 2025Q4: 34,255 shares 34,255$15.5M1.45%-12,700Timeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 61,000 shares; 2024Q4: 56,000 shares; 2025Q1: 37,400 shares; 2025Q2: 136,400 shares; 2025Q3: 119,400 shares; 2025Q4: 146,263 shares 146,263$15.5M1.45%+26,863Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 366,500 shares; 2024Q4: 255,500 shares; 2025Q1: 233,500 shares; 2025Q2: 168,150 shares; 2025Q3: 80,150 shares; 2025Q4: 126,150 shares 126,150$15.5M1.45%+46,000Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,000 shares; 2024Q4: 41,900 shares; 2025Q1: 41,500 shares; 2025Q2: 66,500 shares; 2025Q3: 83,000 shares; 2025Q4: 99,000 shares 99,000$15.5M1.44%+16,000Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 221,400 shares; 2024Q4: 197,700 shares; 2025Q1: 126,700 shares; 2025Q2: 136,429 shares; 2025Q3: 58,429 shares; 2025Q4: 76,504 shares 76,504$15.2M1.42%+18,075Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 364,500 shares; 2024Q4: 250,623 shares; 2025Q1: 265,000 shares; 2025Q2: 149,650 shares; 2025Q3: 186,650 shares; 2025Q4: 215,000 shares 215,000$12.8M1.19%+28,350Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,000 shares; 2024Q4: 145,500 shares; 2025Q1: 124,300 shares; 2025Q2: 109,030 shares; 2025Q3: 95,030 shares; 2025Q4: 74,030 shares 74,030$12.6M1.18%-21,000Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 195,000 shares; 2024Q4: 212,500 shares; 2025Q1: 81,000 shares; 2025Q2: 182,000 shares; 2025Q3: 310,000 shares; 2025Q4: 158,500 shares 158,500$12.5M1.17%-151,500Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,000 shares; 2024Q4: 3,000 shares; 2025Q1: 4,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 36,000 shares 36,000$11.8M1.1%newTimeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,000 shares; 2025Q3: 53,000 shares; 2025Q4: 190,000 shares 190,000$11.7M1.09%+137,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,300 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,250 shares; 2025Q4: 19,550 shares 19,550$11.4M1.06%+1,300Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 41,685 shares; 2024Q4: 78,385 shares; 2025Q1: 28,200 shares; 2025Q2: 32,000 shares; 2025Q3: 46,500 shares; 2025Q4: 38,650 shares 38,650$10.6M0.99%-7,850Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 70,000 shares; 2025Q2: 135,100 shares; 2025Q3: 180,100 shares; 2025Q4: 147,600 shares 147,600$10.3M0.96%-32,500Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 259,500 shares; 2024Q4: 232,000 shares; 2025Q1: 433,000 shares; 2025Q2: 574,000 shares; 2025Q3: 574,000 shares; 2025Q4: 487,000 shares 487,000$10.2M0.96%-87,000Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 300,000 shares; 2024Q4: 290,000 shares; 2025Q1: 249,336 shares; 2025Q2: 185,000 shares; 2025Q3: 347,500 shares; 2025Q4: 537,500 shares 537,500$10.2M0.95%+190,000Timeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 357,346 shares 357,346$10.1M0.94%newTimeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 495,000 shares; 2025Q4: 605,000 shares 605,000$9.83M0.92%+110,000Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,200 shares; 2025Q2: 21,500 shares; 2025Q3: 20,500 shares; 2025Q4: 31,500 shares 31,500$9.79M0.92%+11,000Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 144,500 shares 144,500$9.59M0.9%newTimeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 367,500 shares; 2024Q4: 195,591 shares; 2025Q1: 28,250 shares; 2025Q2: 93,250 shares; 2025Q3: 232,250 shares; 2025Q4: 374,450 shares 374,450$9.41M0.88%+142,200Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 231,000 shares; 2024Q4: 123,410 shares; 2025Q1: 138,500 shares; 2025Q2: 57,500 shares; 2025Q3: 31,000 shares; 2025Q4: 40,500 shares 40,500$9.28M0.87%+9,500Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 166,526 shares; 2024Q4: 314,526 shares; 2025Q1: 195,000 shares; 2025Q2: 250,000 shares; 2025Q3: 490,000 shares; 2025Q4: 872,000 shares 872,000$9.06M0.85%+382,000Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 32,000 shares; 2024Q4: 43,500 shares; 2025Q1: 43,500 shares; 2025Q2: 67,250 shares; 2025Q3: 65,250 shares; 2025Q4: 133,500 shares 133,500$8.7M0.81%+68,250Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 127,500 shares; 2024Q4: 82,000 shares; 2025Q1: 39,500 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares 250,000$8.64M0.81%newTimeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 105,000 shares; 2024Q4: 73,755 shares; 2025Q1: 73,755 shares; 2025Q2: 65,755 shares; 2025Q3: 56,255 shares; 2025Q4: 106,255 shares 106,255$8.39M0.78%+50,000Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 80,000 shares 80,000$8.17M0.76%+30,000Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 613,500 shares; 2024Q4: 595,000 shares; 2025Q1: 411,000 shares; 2025Q2: 344,000 shares; 2025Q3: 258,500 shares; 2025Q4: 206,500 shares 206,500$7.98M0.75%-52,000Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 198,000 shares 198,000$7.42M0.69%+138,000Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,315 shares; 2024Q4: 36,315 shares; 2025Q1: 42,315 shares; 2025Q2: 123,315 shares; 2025Q3: 154,315 shares; 2025Q4: 147,315 shares 147,315$6.94M0.65%-7,000Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares; 2025Q4: 216,000 shares 216,000$6.86M0.64%-34,000Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 268,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 81,600 shares 81,600$6.24M0.58%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 35,000 shares; 2025Q2: 35,000 shares; 2025Q3: 81,000 shares; 2025Q4: 139,000 shares 139,000$6.23M0.58%+58,000Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,290,000 shares; 2025Q2: 1,250,763 shares; 2025Q3: 1,250,763 shares; 2025Q4: 1,238,625 shares 1,238,625$6.18M0.58%-12,138Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,000 shares; 2024Q4: 23,750 shares; 2025Q1: 17,750 shares; 2025Q2: 12,750 shares; 2025Q3: 11,750 shares; 2025Q4: 25,000 shares 25,000$6.16M0.58%+13,250Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 48,000 shares; 2024Q4: 29,000 shares; 2025Q1: 22,000 shares; 2025Q2: 13,000 shares; 2025Q3: 19,500 shares; 2025Q4: 26,500 shares 26,500$5.97M0.56%+7,000Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 58,278 shares; 2024Q4: 58,278 shares; 2025Q1: 28,278 shares; 2025Q2: 28,278 shares; 2025Q3: 28,278 shares; 2025Q4: 153,278 shares 153,278$5.32M0.5%+125,000Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,500 shares; 2024Q4: 23,150 shares; 2025Q1: 48,950 shares; 2025Q2: 44,650 shares; 2025Q3: 22,500 shares; 2025Q4: 15,000 shares 15,000$5.26M0.49%-7,500Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 165,000 shares; 2025Q4: 142,571 shares 142,571$5.17M0.48%-22,429Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 207,000 shares; 2025Q4: 364,000 shares 364,000$4.8M0.45%+157,000Timeline
CRLCHARLES RIV LABS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 37,500 shares; 2024Q4: 14,850 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 22,000 shares 22,000$4.39M0.41%newTimeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,052,500 shares; 2024Q4: 1,235,448 shares; 2025Q1: 647,827 shares; 2025Q2: 647,827 shares; 2025Q3: 1,097,827 shares; 2025Q4: 1,595,327 shares 1,595,327$4.36M0.41%+497,500Timeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,000 shares; 2025Q3: 117,000 shares; 2025Q4: 117,000 shares 117,000$4.21M0.39%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 114,000 shares; 2025Q1: 126,627 shares; 2025Q2: 126,627 shares; 2025Q3: 173,627 shares; 2025Q4: 98,627 shares 98,627$4.06M0.38%-75,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 460,000 shares; 2024Q4: 460,000 shares; 2025Q1: 460,000 shares; 2025Q2: 460,000 shares; 2025Q3: 460,000 shares; 2025Q4: 460,000 shares 460,000$3.89M0.36%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares 35,000$3.75M0.35%0Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,371,147 shares; 2024Q4: 1,362,421 shares; 2025Q1: 1,022,743 shares; 2025Q2: 312,092 shares; 2025Q3: not reported; 2025Q4: 260,000 shares 260,000$3.74M0.35%newTimeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 133,000 shares; 2024Q4: 77,999 shares; 2025Q1: 39,000 shares; 2025Q2: 39,000 shares; 2025Q3: 94,000 shares; 2025Q4: 133,250 shares 133,250$3.73M0.35%+39,250Timeline
RDNTRADNET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 46,000 shares; 2025Q3: 50,000 shares; 2025Q4: 47,000 shares 47,000$3.35M0.31%-3,000Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 122,000 shares; 2024Q4: 150,041 shares; 2025Q1: 16,000 shares; 2025Q2: 30,500 shares; 2025Q3: 61,000 shares; 2025Q4: 35,800 shares 35,800$3.3M0.31%-25,200Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,000 shares; 2025Q4: 265,000 shares 265,000$3.22M0.3%+63,000Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 15,000 shares 15,000$3.2M0.3%newTimeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 106,847 shares; 2024Q4: 170,000 shares; 2025Q1: 141,627 shares; 2025Q2: 55,127 shares; 2025Q3: 100,127 shares; 2025Q4: 225,377 shares 225,377$3.11M0.29%+125,250Timeline
PRVAPRIVIA HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 95,189 shares; 2024Q4: 121,189 shares; 2025Q1: 98,189 shares; 2025Q2: 91,189 shares; 2025Q3: 194,189 shares; 2025Q4: 125,000 shares 125,000$2.96M0.28%-69,189Timeline
STVNSTEVANATO GROUP S P AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 51,000 shares; 2025Q4: 147,025 shares 147,025$2.96M0.28%+96,025Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 102,500 shares; 2024Q4: 90,000 shares; 2025Q1: 100,000 shares; 2025Q2: 85,000 shares; 2025Q3: 216,288 shares; 2025Q4: 83,000 shares 83,000$2.92M0.27%-133,288Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 180,500 shares; 2024Q4: 149,250 shares; 2025Q1: 104,250 shares; 2025Q2: 104,250 shares; 2025Q3: 255,250 shares; 2025Q4: 44,375 shares 44,375$2.82M0.26%-210,875Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares 20,000$2.72M0.25%newTimeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 203,750 shares; 2024Q4: 195,750 shares; 2025Q1: 195,750 shares; 2025Q2: 165,750 shares; 2025Q3: 165,750 shares; 2025Q4: 165,750 shares 165,750$2.54M0.24%0Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares 100,000$2.5M0.23%newTimeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 171,500 shares; 2024Q4: 262,500 shares; 2025Q1: 177,500 shares; 2025Q2: 115,000 shares; 2025Q3: 93,000 shares; 2025Q4: 73,250 shares 73,250$2.18M0.2%-19,750Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 51,000 shares; 2024Q4: 52,750 shares; 2025Q1: 35,750 shares; 2025Q2: 35,870 shares; 2025Q3: 35,870 shares; 2025Q4: 20,870 shares 20,870$1.99M0.19%-15,000Timeline
WSTWEST PHARMACEUTICAL SVSC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,000 shares 7,000$1.93M0.18%newTimeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 116,982 shares; 2024Q4: 195,482 shares; 2025Q1: 126,000 shares; 2025Q2: 99,757 shares; 2025Q3: 170,000 shares; 2025Q4: 46,231 shares 46,231$1.9M0.18%-123,769Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 79,375 shares 79,375$1.9M0.18%newTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares 100,000$1.65M0.15%0Timeline
STESTERIS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,000 shares 6,000$1.52M0.14%newTimeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,000 shares; 2025Q4: 7,000 shares 7,000$1.24M0.12%0Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,000 shares; 2025Q4: 20,000 shares 20,000$421K0.04%+2,000Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
EXASEXACT SCIENCES CORP348,000$19Mshares
CAHCARDINAL HEALTH INC94,000$14.8Mshares
ABTABBOTT LABORATORIES98,500$13.2Mshares
AKROAKERO THERAPEUTICS INC230,600$10.9Mshares
DVAXDYNAVAX TECHNOLOGIES CORP772,000$7.67Mshares
MERUS N VMERUS N V53,500$5.04Mshares
RAREULTRAGENYX PHARMACEUTICAL IN119,400$3.59Mshares
UTHRUNITED THERAPEUTICS CORP DEL8,000$3.35Mshares
ANNXANNEXON INC823,000$2.51Mshares
UHSUNIVERSAL HLTH SVCS INC12,000$2.45Mshares
TECHBIO-TECHNE CORP15,000$834Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-26-015821 base2026-02-13acceptance time not in the bulk data set